LOGIN  |  REGISTER
C4 Therapeutics

Latest Leadership Change News

Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors

May 29
Last Trade: 21.55 0.30 1.41

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors. "As we continue to round out our board's experience, Elizabeth's extensive leadership with some of the largest health plans and deep financial expertise will be invaluable as we scale and innovate across...Read more


Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations

May 28
Last Trade: 29.20 0.00 0.00

Strategic leadership and operational collaboration underscore Claritev’s commitment to growth in the Middle East and international business development outside the US MCLEAN, Va. & ABU DHABI, United Arab Emirates / May 28, 2025 / Business Wire / Claritev Corporation (“Claritev”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is...Read more


Sanuwave Health Appoints Greg Bazar to Board of Directors

May 28
Last Trade: 28.00 0.00 0.00

Bazar brings decades of experience in engineering, computer science and cyber security, AI, and business intelligence over a career of building successful companies EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (Nasdaq:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of Greg Bazar to its Board of...Read more


Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors

May 28
Last Trade: 0.88 0.0077 0.88

SAN DIEGO, CA / ACCESS Newswire / May 28, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, today announced the appointment of Jeff Goldberg to its Board of Directors. Mr. Goldberg brings decades of experience in health care,...Read more


Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value

TAMPA, FLORIDA / ACCESS Newswire / May 28, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company transforming the prescription drug ecosystem, today announced key additions to its executive leadership team and Board of Directors. These strategic appointments reflect the Company's commitment to executing on its growth strategy, enhancing operational scale, and delivering long-term shareholder value. Key...Read more


Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas

May 27
Last Trade: 92.37 0.07 0.08

WARSAW, Ind., May 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kevin Thornal as Group President, Global Businesses and the Americas. Reporting to Chairman-Elect, President and CEO Ivan Tornos, Mr. Thornal will join the Company on July 1, 2025 to oversee the Americas commercial organization and lead business strategy and execution for its...Read more


Acadia Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President, Rare Disease Franchise

May 27
Last Trade: 22.14 4.57 26.01

SAN DIEGO / May 27, 2025 / Business Wire / Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Allyson McMillan-Youngblood as Senior Vice President, Rare Disease Franchise. In this role Allyson will be joining Acadia’s commercial leadership team with a focus on maximizing the potential of DAYBUE® and preparing for future product launches as the Company expands its rare disease portfolio. “We are delighted to...Read more


Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

May 27
Last Trade: 3.35 0.09 2.85

LEXINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to welcome Dr. Dafni Bika to the Company’s Board of Directors (the “Board”). “We are extremely pleased to welcome Dr....Read more


Dr. Mark Stetter Elected to Zoetis Board of Directors

May 22
Last Trade: 166.53 1.13 0.68

Dean of the University of California, Davis School of Veterinary Medicine brings extensive and valuable experience in animal health to Zoetis Board PARSIPPANY, N.J. / May 22, 2025 / Business Wire / Zoetis Inc. (NYSE: ZTS) today announced the election of Dr. Mark Stetter to its Board of Directors, effective as of the company’s annual shareholder meeting on May 21, 2025. Dr. Stetter brings extensive experience in veterinary medicine and...Read more


Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors

May 22
Last Trade: 18.06 0.38 2.15

Dr. Read brings >30 years of leadership and scientific expertise in the biopharmaceutical industry Previously served as CEO and Founder of Mariana Oncology until its acquisition by Novartis in 2024 and CSO of Ra Pharma until its acquisition by UCB in 2020 NEW YORK and WALTHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next...Read more


The Joint Corp. Announces Christopher M. Grandpre Elected as Director

May 22
Last Trade: 10.11 0.03 0.30

Franchise and investment banking expert strengthens the board  SCOTTSDALE, Ariz., May 22, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network dedicated to revolutionizing access to chiropractic care and building a leading wellness franchise with a strong business model, announced Christopher M. Grandpre has been elected as a director...Read more


Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors

May 22
Last Trade: 5.74 0.00 0.00

Renowned neuroscience drug developer joins to support strategic development of long-acting CNS therapeutics  HUNTSVILLE, AL, May 22, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing a pipeline of product candidates leveraging its proprietary POZ Platform™ drug optimization technology, today announced the appointment of Stephen (Steve) Brannan,...Read more


Scienture Announces Executive Leadership Transition

May 22
Last Trade: 0.90 -0.04 -4.30

TAMPA, FL, May 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, today announced that Suren Ajjarapu, who has served as Chief Executive...Read more


CONMED Appoints LaVerne Council as Chair of the Board of Directors

May 21
Last Trade: 57.52 0.45 0.79

LARGO, Fla. / May 21, 2025 / Business Wire / CONMED Corporation (NYSE: CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its Board of Directors, effective May 21, 2025. “LaVerne’s extensive experience as a global operations and information technology executive have been invaluable to CONMED, and I know that her experience will continue to serve the Board and the...Read more


Ardent Health Appoints Chief Development Officer to Lead Strategic Growth

May 19
Last Trade: 14.95 0.13 0.88

BRENTWOOD, Tenn. / May 19, 2025 / Business Wire / Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer. In this new role, Schoeplein will lead development efforts across Ardent’s existing markets and support the organization’s expansion into new regions. He will be responsible for driving growth...Read more


Semler Scientific Appoints Natalie Brunell to its Board of Directors

May 19
Last Trade: 41.21 -0.11 -0.27

CAMPBELL, Calif., May 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, announced the appointment of Natalie Brunell to its board of directors. This strategic addition reflects Semler Scientific's continued commitment to its Bitcoin treasury strategy and further strengthens its...Read more


Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

May 19
Last Trade: 7.23 0.00 0.00

NORWOOD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced the appointment of Rachelle Jacques as Chair of its Board of Directors, effective May 15. She succeeds Alan Holmer, who will remain on the Board. “We thank Alan for his over ten years of dedicated service as founding Chair of the Corbus Board,” said Yuval Cohen,...Read more


Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors

May 19
Last Trade: 0.98 0.005 0.51

Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments ROSELAND, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Shanth Thiyagalingam, BMedSc, MMKTG, MBA, has joined its Board...Read more


Lifeward Names Mark Grant as New CEO

May 19
Last Trade: 1.24 0.005 0.41

Industry veteran brings 30 years of commercial leadership experience MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Mark Grant has been appointed as the Company’s new President and Chief...Read more


Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions

May 19
Last Trade: 0 0.00 0.00

Timothy Kieffer, Ph.D., appointed Chief Scientific Officer Danny Villeneuve appointed Chief Commercial Officer Terrie Kellmeyer, Ph.D., appointed Senior Vice President, Regulatory Affairs Christian Zapf, J.D., appointed General Counsel SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule...Read more


Lars Fruergaard Jørgensen to step down as CEO of Novo Nordisk

May 16
Last Trade: 68.77 0.17 0.25

Bagsværd, Denmark, 16 May 2025 – Novo Nordisk today announced changes to its executive leadership and Board of Directors. As per mutual agreement with the Novo Nordisk Board, Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. He will continue as CEO for a period to support a smooth transition to new leadership. A search for Lars Fruergaard Jørgensen’s successor is ongoing, and an announcement will be made...Read more


Pennant Appoints Suzanne Snapper as Director

May 16
Last Trade: 27.97 0.11 0.39

EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company’s annual shareholder meeting. Ms. Snapper is the Chief Financial Officer of the Ensign...Read more


Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors

May 16
Last Trade: 7.84 0.04 0.51

THOUSAND OAKS, Calif. / May 16, 2025 / Business Wire / Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, announced the appointment of James Huang and Nachi Subramanian to its Board of Directors, effective following the completion the Company’s previously...Read more


Intuitive Announces CEO Transition Effective July 1, 2025

May 15
Last Trade: 555.04 2.62 0.47

President Dave Rosa promoted to CEO Current CEO Gary Guthart to become executive chair of Intuitive’s board Current Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer,...Read more


Covalon Technologies Announces Promotion of Kim Crooks to Chief Operating Officer and Appointment to Board of Directors

May 15
Last Trade: 2.50 -0.07 -2.72

MISSISSAUGA, Ontario / May 15, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce the promotion of Ms. Kim Crooks to the position of Chief Operating Officer (COO), effective immediately. In addition to her new role, Ms. Crooks has been appointed to Covalon's Board of Directors. Ms. Crooks rejoined Covalon in early 2024 as...Read more


GT Biopharma Appoints New Member to its Board of Directors

May 15
Last Trade: 2.79 -0.05 -1.76

SAN FRANCISCO, CALIFORNIA, May 15, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, today announced the appointment of Andrew Ritter to its Board of Directors. Mr. Ritter will be replacing current board member Dr. Rajesh Shrotriya, who is...Read more


Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations

May 14
Last Trade: 41.19 3.50 9.29

Mr. Hand brings more than 20 years of strategic legal and business leadership experience across multiple functions in the biopharmaceutical industry, including nearly a decade in senior executive positions at Celgene Served on Celgene’s Executive Committee and played a key leadership role in the BMS transaction, the integration of Celgene into BMS, and the divestiture of Otezla® to Amgen Appointment marks a key addition as Tonix...Read more


Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors

May 14
Last Trade: 18.19 -1.32 -6.74

SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of healthcare industry veteran Kevin O’Boyle to its Board of Directors and as chair of its Audit Committee. With Mr. O’Boyle’s appointment, the company also announced that Dale E. Jones has...Read more


GT Biopharma Appoints New Member to its Board of Directors

May 14
Last Trade: 2.79 -0.05 -1.76

SAN FRANCISCO, CALIFORNIA, May 14, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, today announced the appointment of Hilary Kramer to its Board of Directors. Mrs. Kramer will be replacing current board member Bruce Wendel, who is...Read more


UnitedHealth Announces Leadership Transition

May 13
Last Trade: 299.90 1.79 0.60

Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026 - / May 13, 2025 / Business Wire / UnitedHealth Group (NYSE: UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty’s decision to step down as CEO for personal reasons....Read more


Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO

May 13
Last Trade: 86.35 -0.63 -0.72

SAN DIEGO / May 13, 2025 / Business Wire / DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his current role as chief operating officer, which he has held since 2022. With more than 21 years of leadership experience at Dexcom, Mr. Leach helped steer the company’s biosensing platforms since the launch of its first commercial...Read more


Neogen Announces Board Transition with Appointment of Andrea Wainer and Retirement of James P. Tobin

LANSING, Mich. / May 13, 2025 / Business Wire / Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that James P. Tobin has chosen to retire from the Company’s Board of Directors, effective May 31, 2025. Mr. Tobin has served on Neogen’s Board since 2016 and currently chairs the Governance and Sustainability Committee and serves on the Audit Committee. James C. Borel, Chair of the Neogen Board...Read more


Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer

May 13
Last Trade: 9.07 0.02 0.22

DUBLIN, May 13, 2025 (GLOBE NEWSWIRE) -- DUBLIN, May 13, 2025 – Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the appointment of Susan Rodriguez as Chief Operating Officer. In this newly created role, Ms. Rodriguez will lead all aspects of the Company's commercial strategy, structure, organization, and related operations,...Read more


Marpai Hires Dallas Scrip As Chief Operating Officer

Marpai Bolsters Leadership Team to Drive Profitable High-Growth Strategy with Key Executive Appointment  TAMPA, Fla., May 13, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, today announced a significant addition to its leadership team with the appointment of Dallas Scrip as Chief Operating Officer (COO) and...Read more


Alpha Tau Medical Announces Appointment of Nadav Kidron to its Board of Directors

May 12
Last Trade: 3.04 0.06 2.01

JERUSALEM, May 12, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that Mr. Nadav Kidron, the President, CEO, and Chairman of the Board of Oramed Pharmaceuticals Inc., (“Oramed”), has been appointed to the Company’s Board of Directors (“Board”). The appointment follows the recent closing of...Read more


Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer

May 12
Last Trade: 3.07 -0.59 -16.12

LEXINGTON, Mass. / May 12, 2025 / Business Wire / Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation today announced that Dr. Richard M. Goldberg, an internationally recognized expert in gastrointestinal (GI) cancer treatment and research, has joined the company as Chief Development Officer. In this role, Dr. Goldberg will lead efforts to advance the botensilimab/balstilimab (BOT/BAL) program for patients and guide the...Read more


Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President

May 12
Last Trade: 0.17 0.00 0.00

Calgary, Alberta, Canada – May 12, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") a radiology contrast media company focused on vertical integration and secure supply chains, is pleased to announce the appointment of Ethan Mohan as Executive Vice President of Voyageur, subject to regulatory approval. Mr. Mohan's appointment is a promotion from his previous position of Sales...Read more


Eli Lilly announces transitions in executive leadership

May 8
Last Trade: 724.02 4.63 0.64

INDIANAPOLIS, May 8, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced executive leadership transitions that will further enhance the company's ability to drive sustained, long-term growth and ensure that its medicines continue to reach millions of people worldwide.Lilly has experienced significant growth over the past several years, particularly in the U.S. and cardiometabolic health businesses. The company...Read more


Establishment Labs Appoints Peter Caldini as Chief Executive Officer

May 7
Last Trade: 35.46 -0.43 -1.20

NEW YORK / May 07, 2025 / Business Wire / Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today the appointment of Peter Caldini as Chief Executive Officer effective May 7, 2025. Mr. Caldini has served as Interim CEO since March 1, 2025, when Establishment Labs’ Founder and previous CEO Juan...Read more


Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

May 6
Last Trade: 47.55 0.58 1.23

Gallman’s Appointment is Effective Immediately Sandra Leung, Executive Vice President, General Counsel Retires After 33 Years of Service PRINCETON, N.J. / May 06, 2025 / Business Wire / Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, effective immediately. Gallman succeeds Sandra (Sandy) Leung, who has chosen to retire after an...Read more


The Joint Strengthens Management Appointing SVP Legal and SVP Operations and Patient Experience

Franchising legal specialist Andra J. Terrell with 20 years of experience in global master, single-unit and multi-unit franchising; compliance strategy; and financing, mergers, acquisitions, and divestitures Franchise operations leader Eric Wyatt with over 30 years of experience to improve clinic economics, enhance the patient experience, and reignite growth  SCOTTSDALE, Ariz., May 06, 2025 (GLOBE NEWSWIRE) -- The Joint Corp....Read more


BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

May 5
Last Trade: 98.36 0.83 0.85

Mainz, Germany, May 5, 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that the Supervisory Board has appointed Ramón Zapata-Gomez to the Management Board as Chief Financial Officer (“CFO”) effective July 1, 2025. He will join BioNTech from Novartis AG’s global biomedical research organization where he has been serving as CFO since 2022. Ramón Zapata will succeed Jens Holstein, who, as...Read more


Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors

May 5
Last Trade: 8.69 0.10 1.16

Directors Rajiv Malik and Harry Korman to Retire at the End of Their Current Terms PITTSBURGH, May 5, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that as part of its ongoing Board refreshment efforts, Frank D'Amelio and Michael Severino, M.D., have been appointed as the newest members of Viatris' Board of Directors. In addition, the Company announced that current...Read more


HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

May 5
Last Trade: 1.53 -0.07 -4.19

Board expansion reflects Company’s commitment to leadership and innovation in remote cardiac monitoring SANTA CLARA, Calif. / May 05, 2025 / Business Wire / HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced the appointment of Chief Executive Officer, Robert Eno, to its Board of Directors. As the Company continues to make...Read more


Modivcare Announces Executive Leadership Transitions as Part of Strategic Business Model Evolution

DENVER / May 05, 2025 / Business Wire / Modivcare Inc. (Nasdaq: MODV), a technology-enabled healthcare services company that provides supportive care solutions to address the social determinants of health, today announced the planned departures of two members of its executive leadership team as the company continues to align its structure with its evolving business model and modernization strategy. Barb Gutierrez, Chief Financial Officer,...Read more


Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

May 1
Last Trade: 32.43 1.04 3.31

SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it has appointed Dr. Olivier Brandicourt, a veteran biopharmaceutical industry executive and the former Chief Executive Officer of Sanofi S.A., to its Board of Directors. “We are thrilled to welcome Olivier to...Read more


BioCryst Pharmaceuticals Appoints Steve Frank to Board of Directors

May 1
Last Trade: 10.73 0.17 1.61

RESEARCH TRIANGLE PARK, N.C., May 01, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed healthcare investment banking leader Steve Frank to its board of directors. Mr. Frank serves as chairman of global healthcare investment banking at J.P. Morgan. He was previously global group head of worldwide healthcare investment banking at Bear Stearns before it was acquired by J.P....Read more


Claritev Appoints Jason Kap to its Board of Directors

May 1
Last Trade: 29.20 0.00 0.00

Board gains deep technology and innovation expertise to support Claritev’s tech-driven growth strategy MCLEAN, Va. / May 01, 2025 / Business Wire / Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, yesterday announced the appointment of Jason Kap to its Board of Directors, effective immediately following...Read more


Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development

May 1
Last Trade: 22.61 -0.08 -0.35

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that Nicole Davarpanah, M.D., J.D. has been promoted to chief medical officer (CMO), and Corrina Pavetto has been promoted to senior vice president, clinical development, effective May 1, 2025. “These promotions come...Read more


Foghorn Therapeutics Appoints Neil Gallagher and Stuart Duty to its Board of Directors

May 1
Last Trade: 4.44 0.14 3.14

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced the election of Neil Gallagher, M.D., Ph.D., and Stuart Duty, to its Board of Directors. “Neil and Stuart are experienced leaders with decades of deep and multifaceted understanding of the...Read more


Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology

May 1
Last Trade: 1.29 -0.01 -0.77

Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs and antibody therapies ranging from early discovery to pre-clinical/clinical stage 25+ year-career experience bolsters Company’s efforts to address growing, high-value ADC market and maximize opportunities for non-dilutive...Read more


Voyageur Pharmaceuticals Announces Changes to Board of Directors and DSU Grant

May 1
Last Trade: 0.17 0.00 0.00

FOR IMMEDIATE RELEASE Ralph Hesje Retires as Chairman  Eric Pommer Assumes Role of Chairperson  Beth Shaw Appointed to Board  CALGARY, AB – TheNewswire - May 1, 2025 – Voyageur Pharmaceuticals Ltd. (the "Company" or "Voyageur") is pleased to announce changes to the board of directors of the Company (the "Board"), marking a new chapter in the Company’s growth trajectory. Retirement of Ralph Hesje After...Read more


CooperCompanies Appoints Barbara Carbone to Board of Directors

April 30
Last Trade: 80.27 0.15 0.19

SAN RAMON, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Barbara Carbone as an independent director, effective May 1, 2025. Ms. Carbone has also been appointed to serve on the Audit Committee when she joins the Board. Ms. Carbone brings nearly four decades of experience across a wide variety of industries. She...Read more


Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors

April 30
Last Trade: 1.49 0.07 5.26

BRIDGEWATER, NJ / ACCESS Newswire / April 30, 2025 / Tharimmune, Inc., (NASDAQ:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology, today announced the appointment of Clay Kahler and Gary Stetz to its Board of Directors, increasing the Tharimmune Board to nine Directors. As reported in a Form 8-K filed on April 25, 2025, Directors...Read more


Novavax Appoints Charles Newton to Board of Directors

April 29
Last Trade: 7.12 0.20 2.89

GAITHERSBURG, Md., April 29, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced the appointment of Charles Newton to its board as an independent director. Mr. Newton brings extensive experience in public markets and healthcare investment banking to his role on the Novavax Board of Directors. "Charles brings a wealth of expertise across corporate finance and capital markets to Novavax," said John C. Jacobs,...Read more


Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

April 29
Last Trade: 4.00 0.08 2.05

WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced the appointment of Merdad Parsey, M.D., Ph.D. to the company’s board of directors. “We are thrilled to welcome Merdad to our board of directors,” said Mike Raab, president...Read more


Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

April 29
Last Trade: 1.22 -0.06 -4.69

Former Chief Medical Officer of Eli Lilly brings more than thirty years of pharmaceutical industry experience Toronto, Ontario--(Newsfile Corp. - April 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, today announced that pharmaceutical industry...Read more


Rakovina Strengthens Board with Appointments of Yevgeniy Meshcherekov and David Kideckel

April 29
Last Trade: 0.06 0.00 0.00

VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce the appointments of Mr. Yevgeniy Meshcherekov and Dr. David Kideckel to the Company’s board of directors (the “Board”), subject to receiving approval from the TSX Venture...Read more


Insulet Appoints Ashley McEvoy President and CEO

April 28
Last Trade: 324.70 1.15 0.36

Expects to Exceed First Quarter Revenue Guidance and Raise Full Year 2025 Guidance ACTON, Mass. / Apr 28, 2025 / Business Wire / Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its Board of Directors has appointed Ashley McEvoy President and Chief Executive Officer and a member of the Board of Directors, effective...Read more


Scholar Rock Appoints David L. Hallal as Chief Executive Officer; Also Announces Addition of Three Key Leaders to Scale for Next Phase of Growth

April 28
Last Trade: 29.49 0.63 2.18

David Hallal has served as Chairman of the Board of Directors since 2017; ensures seamless transition ahead of global launch of apitegromab for Spinal Muscular Atrophy Jay Backstrom, M.D., to serve as strategic advisor as part of planned transition, continuing to work closely with executive team and Board of Directors Akshay Vaishnaw, M.D., Ph.D., appointed to newly created role of President of R&D; has served as Board member since...Read more


Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board

April 28
Last Trade: 10.64 -0.31 -2.83

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Lyn Cobley to its Board of Directors. Ms. Cobley has been a global leader in the financial services industry with over 30 years’ experience in senior positions at international and domestic banks. Ms. Cobley has served as CEO of Westpac Institutional...Read more


ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

April 28
Last Trade: 21.38 1.34 6.69

NEWTOWN SQUARE, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of Merdad Parsey, M.D., Ph.D. to its Board of Directors. Dr. Parsey brings decades of executive experience leading global clinical development in the biopharmaceutical...Read more


Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer

April 28
Last Trade: 1.88 0.05 2.73

CARY, N.C., April 28, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Mark Hensley as Chief Operating Officer. Mr. Hensley has more than fifteen years of experience in a variety of sales and operations positions within the pharmaceutical industry. "I am excited to welcome Mark to Heron as our new Chief...Read more


Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

April 28
Last Trade: 2.20 -0.15 -6.38

CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Esther Rajavelu will serve as its President and Chief Executive Officer, effective May 2, 2025, and will be nominated for election as a member of the...Read more


Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development

April 28
Last Trade: 3.60 0.20 5.88

SAN DIEGO / Apr 28, 2025 / Business Wire / Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced the appointment of Timothy Watkins, M.D., M.Sc., to the Company’s executive team as its Chief Medical Officer and Head of Development. Effective...Read more


Modivcare Announces Changes to Board of Directors

April 25
Last Trade: 1.06 0.17 19.10

Seasoned Executive Daniel Silvers Brings Decades of Experience in Corporate Finance, Capital Allocation and Public Company Governance DENVER / Apr 25, 2025 / Business Wire / Modivcare Inc. (“Modivcare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Daniel Silvers has been...Read more


West Pharmaceutical Announces Leadership Changes

April 24
Last Trade: 211.63 0.24 0.11

Bernard J. Birkett Announces Intention to Retire from West, Company Initiates Search for a Successor Shane Campbell Appointed Senior Vice President, Chief Proprietary Segment Officer EXTON, Pa., April 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced executive leadership changes as part of its succession planning...Read more


Encompass Health announces promotion of Patrick Tuer to newly established COO position

April 24
Last Trade: 120.34 0.82 0.69

BIRMINGHAM, Ala., April 24, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the promotion of Patrick Tuer from group president to the newly established position of chief operating officer (COO), effective immediately. As COO, Tuer will oversee hospital operations across the organization and will continue reporting to Mark Tarr, president and chief executive officer (CEO) of Encompass Health. "Pat brings...Read more


Integer Announces CEO Succession Plan

April 24
Last Trade: 119.33 -0.06 -0.05

Joseph Dziedzic to retire as President and CEO Payman Khales appointed President and CEO effective October 24, 2025  PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced that Joseph Dziedzic will retire as President and Chief Executive Officer and will step down from the Board of Directors,...Read more


Brookdale Senior Living Appoints Joshua Hausman to Board of Directors

April 24
Last Trade: 6.54 0.04 0.62

Brings Significant Healthcare and Private Capital Investing Expertise, including in Facilities-Based and Senior Care Services Companies Company's Average Director Tenure to be Less Than Four Years after Annual Meeting NASHVILLE, Tenn., April 24, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") today announced that its Board of Directors (the "Board") has appointed Joshua Hausman,...Read more


STAAR Surgical Announces Changes to Board of Directors

April 24
Last Trade: 18.10 0.02 0.11

LAKE FOREST, Calif. / Apr 24, 2025 / Business Wire / STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company’s Board from 2014-2022, as a director, effective April 24, 2025. The Company also...Read more


Helix BioPharma Appoints New COO and Communications Director to Accelerate Growth and Deliver on its Mission Against Hard-to-Treat Cancers

April 24
Last Trade: 0.92 0.00 0.00

Toronto, Ontario – TheNewswire – April 24, 2025 - Helix BioPharma Corp. (TSX: “HBP”, OTC PINK: “HBPCD”, FRANKFURT: “HBP0”) (“Helix” or the “Company”), a clinical-stage oncology company shaping a near future where today’s hard-to-treat cancers are vincible, today announced the appointments of Veronika Kandziora as Chief Operating Officer (“COO”) and Jessica Kourniaktis, DPhil, as Director of Communications of the Company. Ms. Kandziora is...Read more


Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board

April 23
Last Trade: 7.67 0.09 1.19

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced the appointment of Professor...Read more


HEALWELL AI Unveils Strategic Changes to Executive Leadership Team to Drive the Next Phase of Integration, Growth and Shareholder Value Creation

April 23
Last Trade: 1.39 0.02 1.46

Toronto, Ontario--(Newsfile Corp. - April 23, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, today announces a number of key executive appointments to the Company's senior leadership team to reflect HEALWELL's focus on building a high-impact leadership team to guide the Company as it shifts to its next phase of growth, scaling...Read more


Microbot Medical Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

April 23
Last Trade: 2.79 -0.04 -1.45

The addition of a seasoned VP of Marketing compliments the recent hiring of the Company’s VP of Sales to establish its commercialization readiness infrastructure Positive data from the recently published pivotal study raises confidence that LIBERTY® will be well received in the market HINGHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic...Read more


Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director

April 23
Last Trade: 0.38 -0.02 -4.02

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the succession of its Chief Executive Officer (“CEO”), Allan Camaisa, to Eric Poma, Ph.D., who was appointed as CEO and member of the Board of Directors of Calidi (“Board”), effective April 22, 2025. Mr. Camaisa...Read more


Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors

April 23
Last Trade: 0.29 0.02 6.59

HOUSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces the appointment of Kyle Guse, J.D., M.B.A. to the Company’s Board of Directors where he will serve as chair of the Audit Committee and on the Compensation...Read more


Clover Health Announces Changes to Board of Directors

April 22
Last Trade: 3.18 0.05 1.57

WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that after four years of distinguished service, Lee A. Shapiro, a member of Clover Health’s Board of Directors, has notified the Company of his intention not to stand for reelection to the Board of Directors in light of new responsibilities related to his assumption of the...Read more


Evolent Health names Shawn Guertin as new independent nominee for election to its Board of Directors

April 22
Last Trade: 7.51 -0.13 -1.70

Former CFO of CVS Health, Aetna and Coventry Health Care brings deep experience driving growth and profitability. Mr. Guertin's nomination represents continuation of Evolent's board refreshment efforts. WASHINGTON, April 22, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced that a new director nominee will stand...Read more


Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors

April 22
Last Trade: 5.86 -0.30 -4.87

Industry veteran brings deep immunology expertise ahead of key Phase 3 data readout in ulcerative colitis expected in Q3 2025 PARIS, France, April 22, 2025, 10:00 pm CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in...Read more


Sight Sciences Appoints Gary Burbach to its Board of Directors

April 22
Last Trade: 3.69 0.08 2.22

MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today that Gerhard (Gary) F. Burbach was appointed to the Company’s Board of Directors on April 21, 2025. Mr. Burbach will serve as a Class II director with a...Read more


NurExone Biologic Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario

April 22
Last Trade: 0.67 0.00 0.00

TORONTO and HAIFA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering regenerative exosomes-based therapies for central nervous system injuries, is pleased to announce the appointment of Jacob Licht as Chief Executive Officer of Exo-Top Inc. (“Exo-Top”), a wholly owned subsidiary of the Company, and as...Read more


Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402

April 21
Last Trade: 10.89 0.27 2.54

Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director Leadership change is part of a broader strategic transition with Roivant increasing operational involvement and strategic oversight of Immunovant   IND cleared for a potentially registrational program for IMVT-1402 in...Read more


Apellis Pharmaceuticals Announces Craig Wheeler to Join the Board of Directors

April 21
Last Trade: 17.12 0.32 1.90

WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective immediately. Mr. Wheeler is a highly accomplished executive with more than 30 years of leadership experience across the biopharmaceutical industry. “We are thrilled to welcome Craig to the...Read more


Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development

April 21
Last Trade: 11.38 0.15 1.34

VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that Sabeen Mekan, M.D., has been appointed as Senior Vice President, Clinical Development....Read more


OmniAb Announces Two New Appointments to its Board of Directors

April 21
Last Trade: 1.29 0.00 0.00

Philip Gotwals, Ph.D. and Steve Crouse bring strategic and operational experience in business development and global tools and technology EMERYVILLE, Calif. / Apr 21, 2025 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today announced the appointments of Philip J. Gotwals, Ph.D., and Steve Crouse to its Board of Directors. OmniAb also announced the departure of Director Sarah Boyce, who is stepping down following nearly six years of...Read more


IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer's Innovation and AI-Driven Programs

April 21
Last Trade: 0.33 -0.0013 -0.40

Industry Veterans Bring Deep Strategic Experience to Guide Alzheimer's Clinical Expansion and Commercial Strategy POTOMAC, MARYLAND / ACCESS Newswire / April 21, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") today announced the addition of Frank Zaccanelli, Robert K. Coughlin, and Joseph Mangan to its Board of Advisors. The Advisory Board will provide strategic guidance as IGC advances its Alzheimer's...Read more


OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

April 18
Last Trade: 12.36 0.17 1.35

WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that, as part of OptimizeRx’s ongoing process to refresh and expand its board of directors (the “Board”), it intends to appoint a new independent director to its Board of...Read more


NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors

April 17
Last Trade: 17.40 0.09 0.52

NAARDEN, the Netherlands and MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today...Read more


Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

April 17
Last Trade: 21.70 0.80 3.83

SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors. “It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak...Read more


Sign Up To Get Daily
Life Science News

Please review our Disclaimer and Privacy Policy before subscribing.

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE